A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomes

PURPOSE: To report the 5-year biochemical relapse-free survival (BRFS), overall survival (OS), and long-term toxicity outcomes of patients treated with low-dose-rate (LDR) brachytherapy as monotherapy for low- to intermediate-risk prostate cancer. MATERIAL AND METHODS: Between 2004 and 2011, 371 pat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Contemp Brachytherapy
Egile Nagusiak: Chao, Michael, Spencer, Sandra, Guerrieri, Mario, Ding, Wei, Goharian, Mehran, Ho, Huong, Ng, Michael, Healey, Danielle, Tan, Alwin, Cham, Chee, Joon, Daryl Lim, Lawrentschuk, Nathan, Travis, Douglas, Sengupta, Shomik, Chan, Yee, Troy, Andrew, Pham, Trung, Clarke, David, Liodakis, Peter, Bolton, Damien
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Termedia Publishing House 2018
Gaiak:
Review Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5961530/
https://ncbi.nlm.nih.gov/pubmed/29789764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2018.75600
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak